ANGIODYNAMICS, INC.

Public Equity (NASDAQ)PublicMedical DevicesNASDAQ

📍 Latham, NY, USA• Founded 1988• 501-1000 employees

StreetZero Signal 58

Be the first to signal interest

About ANGIODYNAMICS, INC.

AngioDynamics, Inc. designs, manufactures, and markets medical devices for vascular access, peripheral vascular disease treatment, and oncology procedures. The company serves interventional radiologists, cardiologists, and other specialists with minimally invasive solutions. It is publicly traded on NASDAQ under the ticker ANGO and is headquartered in Latham, New York.

LATEST FUNDINGRule 144

$290K

Announced 2026-10-29

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for ANGIODYNAMICS, INC..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

EMPLOYEES501-1000

FOUNDED1988

HQLatham, NY, USA

Industry

Public Equity (NASDAQ)

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Publicly traded on NASDAQ (ANGO)
Focuses on vascular access and oncology devices
Headquartered in Latham, New York
Rule 144 filing reflects secondary share sale activity

Ask StreetZero about ANGIODYNAMICS, INC.

Put our AI to work on this deal.

What is ANGIODYNAMICS, INC.'s value proposition?Who are ANGIODYNAMICS, INC.'s competitors?Why does this raise matter?Summarize ANGIODYNAMICS, INC. for an investor.

Similar companies

Other Public Equity (NASDAQ) deals, ranked by Signal.

Crowdstrike Holdings, Inc.

$141.0M

Paylocity Holding Corporation

$66.0M

BENTLEY SYSTEMS INC

$67.5M

Palo Alto Networks Inc

$201.4M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.